Protein-protein interactions at the adrenergic receptors

Current Drug Targets

Volumn 13, Issue 1, 2012, Pages 15-27

  Cotecchia, Susanna ^a,b   Stanasila, Laura ^a   Diviani, Dario ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Adrenergic receptor subtypes; Arrestins; Receptor oligomerization; Signaling complexes

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR;

OLIGOMERIZATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECEPTORS, ADRENERGIC; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84855841418     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012798868489     Document Type: Review

References (90)

1. Pierce KL, Premont RT, Lefkowitz RJ. Signalling: Seventransmembrane receptors. Nat Rev Mol Cell Biol 2002; 3: 639-50.
2. Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal arrestin. Proc Natl Acad Sci USA 1987; 84: 8879-82.
3. Pitcher JA, Freedman NJ, Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem 1998; 67: 653-92.
4. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. Betaarrestin: a protein that regulates beta-adrenergic receptor function. Science 1990; 248: 1547-50.
5. Goodman OB Jr, Krupnick JG, Santini F, et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 1996; 383(6599): 447-50.
6. De Wire SM, Seungkirl A, Lefkowitz RJ, Shenoy SK. Betaarrestins and cell signaling. Annu Rev Physiol 2007; 69: 483-510.
7. Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42: 409-35.
8. Moore CA, Milano SK, Benovic JL. Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 2007; 69: 451-82.
9. Gurevich VV, Gurevich EV. The structural basis of arrestinmediated regulation of G-protein-coupled receptors. Pharmacol & Therapeutics 2006; 110: 465-502.
10. Shiina T, Kawasaki A, Nagao T, Kurose H. Interaction with betaarrestin determines the difference in internalization behavior between beta1-and beta2-adrenergic receptors. J Biol Chem 2000; 275(37): 29082-90.
11. Tilley DG, Kim IM, Patel PA, Violin JD, Rockman HA. Beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem 2009; 284(30): 20375-86.
12. Nantel F, Bonin H, Emorine LJ, et al. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 1993; 43: 548-55.
13. Cao W, Luttrell LM, Medvedev AV, et al. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 2000; 275(49): 38131-4.
14. DeGraff JL, Gagnon AW, Benovic JL, Orsini MJ. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes. J Biol Chem 1999; 274(16):11253-9.
15. DeGraff JL, Gurevich VV, Benovic JL The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction. J Biol Chem 2002; 277(45): 43247-52.
16. Stanasila L, Abuin L, Dey J, Cotecchia S. Different internalization properties of the alpha1a and alpha1b-adrenergic receptor subytpes: the potential role of receptor interaction with beta-arrestins and AP50. Mol Pharmacol 2008; 74: 562-73.
17. Tang Y, Hu LA, Miller WE, et al. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor. Proc Natl Acad Sci USA 1999; 96(22): 12559-64.
18. Hu LA, Tang Y, Miller WE, et al. Beta1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J Biol Chem 2000; 275(49): 38659-66.
19. Hu LA, Chen W, Premont RT, Cong M, Lefkowitz RJ. G proteincoupled receptor kinase 5 regulates beta 1-adrenergic receptor association with PSD-95. J Biol Chem 2002; 277(2): 1607-13.
20. Xu J, Paquet M, Lau AG, Wood JD, Ross CA, Hall RA. Beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95. J Biol Chem 2001; 276(44): 41310-7.
21. Hu LA, Chen W, Martin NP, Whalen EJ, Premont RT, Lefkowitz RJ. GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. J Biol Chem 2003; 278(28): 26295-301.
22. He J, Bellini M, Xu J, Castleberry AM, Hall RA. Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression. J Biol Chem 2004; 279(48): 50190-6.
23. Pak Y, Pham N, Rotin D. Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation. Mol Cell Biol 2002; 22(22): 7942-52.
24. Xiang Y, Devic E, Kobilka B. The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem 2002; 277(37): 33783-90.
25. He J, Bellini M, Inuzuka H, et al. Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. J Biol Chem 2006; 281(5): 2820-7.
26. Heydorn A, Søndergaard BP, Ersbøll B, et al. A library of 7TM receptor C-terminal tails. Interactions with the proposed postendocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-associated sorting protein (GASP). J Biol Chem 2004; 279(52): 54291-303.
27. Abu-Helo A, Simonin F. Identification and biological significance of G protein-coupled receptor associated sorting proteins (GASPs). Pharmacol & Therapeutics 2010; 126: 244-50.
28. Hicks SW, Horn TA, McCaffery JM, Zuckerman DM, Machamer CE. Golgin-160 promotes cell surface expression of the beta-1 adrenergic receptor. Traffic 2006; 7(12): 1666-77.
29. Tutor AS, Delpón E, Caballero R, et al. Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems. Mol Biol Cell 2006; 17: 4666-74.
30. Richter W, Day P, Agrawal R, et al. Signaling from beta1-and beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J 2008; 27(2): 384-93. beta2
31. Hall RA, Premont RT, Chow CW, et al. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998; 392(6676): 626-30.
32. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY, Shenolikar S. The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu Rev Physiol 2006; 68: 491-505.
33. Maudsley S, Zamah AM, Rahman N, et al. Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 2000; 20(22): 8352-63.
34. Naren AP, Cobb B, Li C, et al. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci USA 2003; 100(1): 342-6.
35. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999; 401(6750): 286-90.
36. Cong M, Perry SJ, Hu LA, Hanson PI, Claing A, Lefkowitz RJ. Binding of the beta2 adrenergic receptor to N-ethylmaleimidesensitive factor regulates receptor recycling. J Biol Chem 2001; 276(48): 45145-52.
37. Xiang Y, Kobilka B. The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc Natl Acad Sci USA 2003; 100(19): 10776-81.
38. Lin F, Wang H, Malbon CC. Gravin-mediated formation of signaling complexes in beta 2-adrenergic receptor desensitization and resensitization. J Biol Chem 2000; 275(25): 19025-34.
39. Fan G, Shumay E, Wang H, Malbon CC. The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta 2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization. J Biol Chem 2001; 276(16): 13240-7.
40. Fraser ID, Cong M, Kim J, et al. Assembly of an A kinaseanchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol 2000; 10(7): 409-12.
41. Cong M, Perry SJ, Lin FT, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem 2001; 276(18): 15192-9.
42. Shih M, Malbon CC. Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors. Cell Signal 1998; 10(8): 575-82.
43. Karoor V, Wang L, Wang HY, Malbon CC. Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem 1998; 273(49): 33035-41.
44. Davare MA, Avdonin V, Hall DD, et al. A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science 2001; 293(5527): 98-101.
45. Liu G, Shi J, Yang L, et al. Assembly of a Ca2+-dependent BK channel signaling complex by binding to beta2 adrenergic receptor. EMBO J 2004; 23(11): 2196-205.
46. Xie L, Xiao K, Whalen EJ, et al. Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal 2009; 2(78): 1-9.
47. Pupo AS, Minneman KP. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol 2002; 2: 17.
48. Xu Q, Xu N, Zhang T, et al. Mammalian tolloid alters subcellular localization, internalization, and signaling of alpha(1a)-adrenergic receptors. Mol Pharmacol 2006; 70(2): 532-41.
49. Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR. Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem 2005; 280: 27289-95.
50. Bernstein LS, Ramineni S, Hague C, et al. RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem 2004; 279(20): 21248-56.
51. Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S. The adaptor complex 2 directly interacts with the alpha1b-adrenergic receptor and plays a role in receptor endocyosis. J Biol Chem 2003; 278: 19331-340.
52. Stanasila L, Abuin L, Diviani D, Cotecchia S. Direct interaction of ezrin with the alpha1b-adrenergic receptor regulates recycling of the internalized receptors. J Biol Chem 2006; 281: 4354-63.
53. Pupo AS, Minneman KP. Specific interactions between gC1qR and alpha1-adrenoceptor subtypes. J Recept Signal Transduct Res 2003; 23(2-3): 185-95.
54. Chen Z, Hague C, Hall RA, Minneman KP. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. J Biol Chem 2006; 281(18): 12414-20.
55. Prezeau L, Richman JG, Edwards SW, Limbird LE. The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes. J Biol Chem 2002; 277: 50589-96.
56. Wang Q, Limbird LE. Regulated interactions of the alpha 2A adrenergic receptor with spinophilin, 14-3-3zeta, and arrestin 3. J Biol Chem 2002; 277(52): 50589-96.
57. Richman JG, Brady AE, Wang Q, Hensel JL, Colbran RJ, Limbird LE. Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin. J Biol Chem 2001; 276(18): 15003-8.
58. Wang Q, Limbird LE. Regulation of alpha2AR trafficking and signaling by interacting proteins. Biochem Pharmacol 2007; 73(8): 1135-45.
59. Brady AE, Wang Q, Colbran RJ, Allen PB, Greengard P, Limbird LE. Spinophilin stabilizes cell surface expression of alpha 2Badrenergic receptors. J Biol Chem 2003; 278(34): 32405-12.
60. Wang Q, Zhao J, Brady AE, et al. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 2004; 304(5679): 1940-4.
61. Wang X, Zeng W, Kim MS, Allen PB, Greengard P, Muallem S. Spinophilin/neurabin reciprocally regulate signaling intensity by G protein-coupled receptors. EMBO J 2007; 26(11): 2768-76.
62. Weber B, Schaper C, Wang Y, Scholz J, Bein B. Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation. Cell Signal 2009; 21(10): 1513-21.
63. Hebert TE, Moffett S, Morello JP, et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996; 271(27): 16384-92.
64. Angers S, Salahpour A, Joly E, et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000; 97(7): 3684-9.
65. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M. Quantitative assessment of beta 1 and beta 2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 2002; 277(47): 44925-31
66. Stanasila L, Perez JB, Vogel H, Cotecchia S. Oligomerization of the alpha1a-and alpha1b-adrenergic receptor subytpes: potential implications in receptor internalization. J Biol Chem 2003; 278: 40239-51.
67. Uberti MA, Hall RA, Minneman KP. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 2003; 64(6): 1379-90.
68. Small KM, Schwarb MR, Glinka C, et al. Alpha2A-and alpha2Cadrenergic receptors form homo-and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment. Biochemistry 2006; 45(15): 4760-7.
69. Zhou F, Filipeanu CM, Duvernay MT, Wu G. Cell-surface targeting of alpha2-adrenergic receptors--inhibition by a transport deficient mutant through dimerization. Cell Signal 2006; 18(3): 318-27.
70. Gouldson PR, Snell CR, Bywater RP, Higgs C, Reynolds CA. Domain swapping in G-protein coupled receptor dimers. Protein Eng 1998; 11(12): 1181-93.
71. Carrillo JJ, López-Giménez JF, Milligan G. Multiple interactions between transmembrane helices generate the oligomeric alpha1badrenoceptor. Mol Pharmacol 2004; 66(5): 1123-37.
72. Salahpour A, Angers S, Mercier JF, Lagacé M, Marullo S, Bouvier M. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 2004; 279(32): 33390-7.
73. Cao TT, Brelot A, von Zastrow M. The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis. Mol Pharmacol 2005; 67(1): 288-97.
74. Lavoie C, Mercier JF, Salahpour A, et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 2002; 277(38): 35402-10.
75. Breit A, Lagacé M, Bouvier M. Hetero-oligomerization between beta2-and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004; 279(27): 28756-65.
76. Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J Biol Chem 2004; 279(15): 15541-9.
77. Uberti MA, Hague C, Oller H, Minneman KP, Hall RA. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 2005; 313(1): 16-23.
78. Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, Hall RA. Heterodimerization of alpha 2A-and beta 1-adrenergic receptors. J Biol Chem 2003; 278(12): 10770-7.
79. Prinster SC, Holmqvist TG, Hall RA. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors. J Pharmacol Exp Ther 2006; 318(3): 974-81.
80. Hague C, Uberti MA, Chen Z, et al. Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. Proc Natl Acad Sci USA 2004; 101(37): 13672-6.
81. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 2001; 98(1): 343-8.
82. Barki-Harrington L, Luttrell LM, Rockman HA. Dual inhibition of beta-adrenergic and angiotensin II receptors by single antagonist. Circulation 2003; 108: 1611-8.
83. Berthouze M, Ayoub M, Russo O, et al. Constitutive dimerization of human serotonin 5HT4 receptors in living cells. Febs Lett 2005; 579: 2973-80.
84. McGraw DW, Mihlbachler KA, Schwarb MR, et al. Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex. J Clin Invest 2006; 116(5): 1400-9.
85. Hudson BD, Hébert TE, Kelly MEM. Physical and functional interaction of CB1 cannabinoid receptors and beta2-adrenoceptors. Br J Pharmacol 2010; 160: 627-42.
86. Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 2003; 64(6): 1317-24
87. Rios C, Gomes I, Devi LA. Interactions between delta opioid receptors and alpha-adrenoceptors. Clin Exp Pharmacol Physiol 2004; 31(11): 833-6.
88. Joiner ML, Lisé MF, Yuen EY, et al. Assembly of a beta2-adrenergic receptor--GluR1 signalling complex for localized cAMP signalling. EMBO J 2010; 29(2): 482-95.
89. Dev KK. Making protein interactions druggable: targeting the PDZ domains. Nat Rev Drug Discov 2004; 3: 1047-56.
90. Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptorinteracting proteins. Nat Rev Mol Cell Biol 2009; 10: 819-30.